# Study of Chemotherapy and Patient Health Outcomes for Nausea and Emesis (0000-041)

> **NCT00211601** · NA · COMPLETED · sponsor: **Merck Sharp & Dohme LLC** · enrollment: 1500 (—)

## Conditions studied

- Chemotherapy Induced Nausea and Vomiting

## Interventions

- **BEHAVIORAL:** Disease Management Assessment

## Key facts

- **NCT ID:** NCT00211601
- **Lead sponsor:** Merck Sharp & Dohme LLC
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-08
- **Primary completion:** 2005-12
- **Final completion:** 2005-12
- **Target enrollment:** 1500 (—)
- **Last updated:** 2015-05-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00211601

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00211601, "Study of Chemotherapy and Patient Health Outcomes for Nausea and Emesis (0000-041)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00211601. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*